Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1610661

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1610661

Global Synthetic Biology Market Size Study, by Product, by Technology, by Application, by End Use and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The global synthetic biology market is estimated to be valued at USD 13.83 billion in 2023, poised to expand with a robust CAGR of 17.30% from 2024 to 2032. Synthetic biology, which has evolved into a transformative technology, is making significant strides across healthcare, energy, agriculture, and material industries. The market growth is driven by its emerging applications in multiplexed diagnostics, genome editing, and therapeutic innovations, which are unlocking new opportunities for industry stakeholders.

Synthetic biology's adoption gained unprecedented momentum during the COVID-19 pandemic as researchers utilized it to develop vaccines, test kits, and therapies. This period highlighted the versatility and potential of synthetic biology, particularly in enhancing vaccine development timelines. Moreover, advancements in genome editing tools and biofoundries have paved the way for bio-based economies, further broadening the applications of synthetic biology across industries like bioplastics, biofuels, and sustainable materials. Companies such as Bolt Threads and Modern Meadow exemplify this trend by integrating biotechnology to create eco-friendly materials for various commercial applications.

Synthetic biology's growing importance is further underscored by strategic investments in research institutions and innovative product launches. For instance, the launch of the Rice Synthetic Biology Institute aims to catalyze breakthroughs that translate into societal benefits. However, the market's long-term success depends on addressing infrastructural and regulatory challenges through public-private partnerships and comprehensive governance frameworks.

Geographically, North America dominated the market in 2024, benefiting from robust public and private investments and a thriving research ecosystem. Asia Pacific is anticipated to register the fastest CAGR during the forecast period, fueled by industrialization and significant investments in healthcare and life sciences infrastructure. Key regions like Europe are leveraging synthetic biology for sustainable solutions in agriculture and energy, further diversifying its applications.

The global synthetic biology market is experiencing a paradigm shift, driven by advancements in genome editing, increased research funding, and a growing focus on sustainability. As industry players innovate and collaborate, the sector is set to witness transformative growth, offering immense opportunities across diverse sectors.

Major market players included in this report are:

  • Codexis, Inc.
  • Merck Kgaa (Sigma-Aldrich Co. Llc)
  • Illumina, Inc.
  • Novozymes
  • Bota Biosciences Inc.
  • Pareto Bio, Inc.
  • Creative Biogene.
  • Creative Enzymes.
  • Thermo Fisher Scientific, Inc.
  • New England Biolabs
  • Scarab Genomics, Llc
  • Enbiotix, Inc.
  • Synthego
  • Synthetic Genomics Inc.
  • Eurofins Scientific

The detailed segments and sub-segment of the market are explained below:

By Product

  • Enzymes
  • Cloning Technologies Kits
  • Others

By Technology

  • PCR
  • Genome Editing
  • Others

By Application

  • Healthcare
  • Non-Healthcare

By End Use

  • Biotechnology & Pharmaceutical Companies
  • Academic and Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe (ROE)
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa (RoMEA)

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Synthetic Biology Market Executive Summary

  • 1.1. Global Synthetic Biology Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Technology
    • 1.3.3. By Application
    • 1.3.4. By End Use
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Synthetic Biology Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Synthetic Biology Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rise in Applications Across Diverse Sectors
    • 3.1.2. Advancements in Genome Editing Technologies
    • 3.1.3. Growing Focus on Sustainability
  • 3.2. Market Challenges
    • 3.2.1. Infrastructure and Regulatory Barriers
    • 3.2.2. High Costs of R&D
  • 3.3. Market Opportunities
    • 3.3.1. Expanding Applications in Bio-Based Economies
    • 3.3.2. Increasing Public-Private Collaborations

Chapter 4. Global Synthetic Biology Market Industry Analysis

  • 4.1. Porter's Five Force Model
  • 4.2. PESTEL Analysis
  • 4.3. Top Investment Opportunities
  • 4.4. Disruptive Trends
  • 4.5. Analyst Recommendations

Chapter 5. Global Synthetic Biology Market Size & Forecast by Product (2022-2032)

  • 5.1. Segment Dashboard
  • 5.2. Revenue Trend Analysis (USD Billion)
    • 5.2.1. Enzymes
    • 5.2.2. Cloning Technologies Kits
    • 5.2.3. Others

Chapter 6. Global Synthetic Biology Market Size & Forecast by Technology (2022-2032)

  • 6.1. Segment Dashboard
  • 6.2. Revenue Trend Analysis (USD Billion)
    • 6.2.1. PCR
    • 6.2.2. Genome Editing
    • 6.2.3. Others

Chapter 7. Global Synthetic Biology Market Size & Forecast by Application (2022-2032)

  • 7.1. Segment Dashboard
  • 7.2. Revenue Trend Analysis (USD Billion)
    • 7.2.1. Healthcare
    • 7.2.2. Non-Healthcare

Chapter 8. Global Synthetic Biology Market Size & Forecast by End Use (2022-2032)

  • 8.1. Segment Dashboard
  • 8.2. Revenue Trend Analysis (USD Billion)
    • 8.2.1. Biotechnology & Pharmaceutical Companies
    • 8.2.2. Academic and Research Institutes

Chapter 9. Global Synthetic Biology Market Size & Forecast by Region (2022-2032)

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
  • 9.2. Europe
    • 9.2.1. UK
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. ROE
  • 9.3. Asia Pacific
    • 9.3.1. China
    • 9.3.2. India
    • 9.3.3. Japan
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. RoAPAC
  • 9.4. Latin America
    • 9.4.1. Brazil
    • 9.4.2. Mexico
  • 9.5. Middle East & Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. South Africa
    • 9.5.3. RoMEA

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Codexis, Inc.
    • 10.1.2. Illumina, Inc.
    • 10.1.3. Thermo Fisher Scientific, Inc.
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!